Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
AstraZeneca
Merck
McKinsey
Baxter

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Litigation Details for Takeda Pharmaceutical Company Limited v. Teva Pharmaceuticals USA Inc. (D. Del. 2007)

See Plans and Pricing

« Back to Dashboard

Takeda Pharmaceutical Company Limited v. Teva Pharmaceuticals USA Inc. (D. Del. 2007)

Docket   Start Trial Date Filed 2007-05-25
Court District Court, D. Delaware Date Terminated 2009-11-10
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties CAESAR, RIVISE, BERNSTEIN, COHEN & POKOTILOW, LTD.; ETHYPHARM S.A.; TAKEDA PHARMACEUTICAL COMPANY LIMITED; TAKEDA PHARMACEUTICALS AMERICA INC.; TAKEDA PHARMACEUTICALS LLC; TAKEDA PHARMACEUTICALS NORTH AMERICA INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA INC.
Patents 4,628,098; 5,026,560; 5,045,321
Attorneys Ann G. Fort; Arlene L. Chow; Chad J. Peterman; Dillon Kim; Eric J. Lobenfeld; James Walter Parrett , Jr.; John G. Day; Karen L. Pascale; Laura F. Fritts; Lauren E. Maguire; Mary B. Graham; Philippe Y. Riesen; Richard V. de Bodo; Rodger Dallery Smith , II; Steven J. Balick; Stuart E. Pollack; Tedd W. Van Buskirk
Link to Docket External link to docket
Small Molecule Drugs cited in Takeda Pharmaceutical Company Limited v. Teva Pharmaceuticals USA Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Takeda Pharmaceutical Company Limited v. Teva Pharmaceuticals USA Inc. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-05-25 1 Complaint States Patent and Trademark Office (“the PTO”) issued U.S. Patent No. 4,628,098 (“the ’098 Patent”), entitled…being the record owner of U.S. Patent No. 5,464,632 (“the ’632 Patent”). Ethypharm seeks relief in this…of the ’098 Patent, and Plaintiff TAP is the exclusive licensee. A copy of the ’098 Patent is attached…September 3, 1991, the PTO issued U.S. Patent No. 5,045,321 (“the ’321 Patent”), entitled “Stabilized Pharmaceutical…of the ’321 Patent, and Plaintiff TAP is the exclusive licensee. A copy of the ’321 Patent is attached External link to document
2007-06-21 11 Answer to Complaint and enforceable claim of U.S. Patent 4,628,098 ("the '098 Patent"). Furthermore, Teva Ltd… the '098 patent, the '321 patent, the '632 patent, and the '994 patent (collectively …the ‘098 patent unenforceable SEVENTH DEFENSE The patent term extension for the ‘098 patent is unenforceable…and enforceable claim of U.S. Patent 5,045,321 ("the '321 Patent"). Furthermore, Teva Ltd…and enforceable claim of U.S. Patent 6,328,994 ("the '994 Patent“). Furthermore, Teva Ltd. has External link to document
2009-11-09 149 Memorandum Opinion asserted the ‘632 patent, as well as U.S. Patent Nos. 4,628,098 (“the ‘098 patent"), 5,045,321 (…claimed in a patent or the use of which is claimed in a patent before the expiration of such patent."’…the exclusive licensees of U.S. Patent No. 5,464,632 (“the ‘632 patent"), which claims a rapidly … (“the ‘321 patent"), and 6,328,994 (“the ‘994 patent”) against defendants Defendants responded in…Act for a drug claimed in a patent or the use of which is claimed in a patent[.]" Case 1:07-cv-00331 External link to document
2007-07-20 15 Answer to Counterclaim and validity of certain claims of U.S. Patent Nos. 4,628,098, 5,045,321, 5,464,632, and 6,328,994, and…Declaration of Unenforceability of the Patent Term Extension for the ‘098 Patent) 23. Plaintiffs…‘098 patent issued on December 9, 1986, admit that on July 6, 1995, Takeda applied for a Patent Term …awarded Takeda a Patent Term Extension of 1381 days extending the term of the patent to May 10, 2009.… (Non-Infringement of the ‘098 Patent) 6. Plaintiffs repeat and External link to document
2007-07-25 17 Letter the validity or enforceability of U.S. Patent Nos. 4,628,098 and 5,045,321, which are the subject of … validity and/or enforceability of U.S. Patent Nos. 4,628,098 and/or 5,045,321 in the ’06 Action shall…strictly related to the validity of U.S. Patent Nos. 4,628,098 and 5,045,321 (“the ‘06 Action”). Any tinal…judgment with respect to the validity of U.S. Patent Nos. 4,628,098 and/or 5,045,321 in the ‘06 Action shall… infringement or noninfringement of U.S. Patent No. 4,628,098 shall be binding upon the parties in this External link to document
2007-07-25 18 Letter the validity or enforceability of U.S. Patent Nos. 4,628,098 and 5,045,321, which are the subject of…validity and/or enforceability of U.S. Patent Nos. 4,628,098 and/or 5,045,321 in the ’06 Action shall…strictly related to the validity of U.S. Patent Nos. 4,628,098 and 5,045,321 (“the ‘06 Action”). Any final…judgment with respect to the validity of U.S. Patent Nos. 4,628,098 and/or 5,045,321 in the ‘06 Action shall…infringement or noninfringement of U.S. Patent No. 4,628,098 shall be binding upon the parties in this External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Mallinckrodt
Medtronic
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.